152 related articles for article (PubMed ID: 19850477)
1. Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand?
Wang J; Kollias J; Marsh C; Maddern G
Breast; 2009 Dec; 18(6):378-81. PubMed ID: 19850477
[TBL] [Abstract][Full Text] [Related]
2. Male breast cancer: management and follow-up recommendations.
Kiluk JV; Lee MC; Park CK; Meade T; Minton S; Harris E; Kim J; Laronga C
Breast J; 2011; 17(5):503-9. PubMed ID: 21883641
[TBL] [Abstract][Full Text] [Related]
3. National Breast Cancer Audit: overview of invasive breast cancer in New Zealand.
Ooi CW; Campbell ID; Kollias J; de Silva P
N Z Med J; 2012 Aug; 125(1359):7-16. PubMed ID: 22932509
[TBL] [Abstract][Full Text] [Related]
4. Are there changes in characteristics and therapy of young patients with early-onset breast cancer in Germany over the last decade?
Banz-Jansen C; Heinrichs A; Hedderich M; Waldmann A; Wedel B; Mebes I; Diedrich K; Rody A; Fischer D
Arch Gynecol Obstet; 2013 Aug; 288(2):379-83. PubMed ID: 23407999
[TBL] [Abstract][Full Text] [Related]
5. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy after neo-adjuvant chemotherapy in breast cancer.
Stell VH; Flippo-Morton TS; James Norton H; White RL
Breast J; 2011; 17(1):71-4. PubMed ID: 21129099
[TBL] [Abstract][Full Text] [Related]
7. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
8. National breast cancer audit: overview of invasive breast cancer management.
Cuncins-Hearn AV; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
ANZ J Surg; 2006 Aug; 76(8):745-50. PubMed ID: 16916399
[TBL] [Abstract][Full Text] [Related]
9. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
10. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
[TBL] [Abstract][Full Text] [Related]
11. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.
García Fernández A; Chabrera C; García Font M; Fraile M; Lain JM; Barco I; González C; Gónzalez S; Reñe A; Veloso E; Cassadó J; Pessarrodona A; Giménez N
Breast; 2013 Oct; 22(5):902-7. PubMed ID: 23684000
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
13. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
15. The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial--results from the BreastSurgANZ National Breast Cancer Audit.
Ainsworth RK; Kollias J; Le Blanc A; De Silva P
Breast; 2013 Oct; 22(5):733-5. PubMed ID: 23290275
[TBL] [Abstract][Full Text] [Related]
16. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
[TBL] [Abstract][Full Text] [Related]
17. Axillary node staging for microinvasive breast cancer: is it justified?
Lyons JM; Stempel M; Van Zee KJ; Cody HS
Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
[TBL] [Abstract][Full Text] [Related]
18. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
[TBL] [Abstract][Full Text] [Related]
19. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
20. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.
Liukkonen S; Saarto T; Mäenpää H; Sjöström-Mattson J
Acta Oncol; 2010 Apr; 49(3):322-7. PubMed ID: 20397767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
